Farallon Capital Partners, L.P.

Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

Symbol: CRNX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned: 8,024,098 shares
Security Ownership %: 8.5%

Dapice Joshua J. ownership in Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX)

05 Feb 2026 - Dapice Joshua J. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,024,098 shares of Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX). This represents 8.5% ownership of the company. In their previous filing dated 08 Sep 2025, Farallon Capital Partners, L.P. had reported owning 5,625,098 shares, indicating an increase of +43%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Dapice Joshua J.	8.5%	+42%	$373,521,762	8,024,098	+2,399,000	+43%	$46.55	13G/A	31 Dec 2025	05 Feb 2026, 14:45
Dapice Joshua J.	6%		$164,477,866	5,625,098			$29.24	13G	29 Aug 2025	08 Sep 2025, 17:36